Skip to main content
Hand (New York, N.Y.) logoLink to Hand (New York, N.Y.)
. 2024 Sep 26;20(8):1182–1189. doi: 10.1177/15589447241278972

Diagnostic Accuracy of Neuromuscular Ultrasound vs. Electrodiagnostic Studies for Carpal Tunnel Syndrome: Systematic Review and Meta-analysis of Paired Accuracy Studies

Larry E Miller 1,✉, Warren C Hammert 2, Mark S Rekant 3, John R Fowler 4
PMCID: PMC11559833  PMID: 39324685

Abstract

This systematic review with meta-analysis compared the diagnostic accuracy of neuromuscular ultrasound (NMUS) and electrodiagnostic studies (EDX) as confirmatory tests for carpal tunnel syndrome (CTS) diagnosis. We used bivariate random-effects models to estimate pooled sensitivity and specificity and generate hierarchical summary receiver-operating characteristic curves to assess diagnostic test accuracy. Nine paired accuracy studies were included, representing 1751 hands (743 clinically diagnosed CTS; 1008 without CTS) that underwent NMUS and EDX. Compared to the clinical diagnosis reference standard, the pooled sensitivity was 86.4% for NMUS and 91.6% for EDX. Pooled specificity was 79.3% for NMUS and 81.9% for EDX. The positive likelihood ratios were 4.2 and 5.1 for NMUS and EDX, respectively, and the negative likelihood ratios were 0.17 and 0.10, respectively. The diagnostic odds ratio was 24 for NMUS and 49 for EDX. No statistically significant differences were identified between NMUS and EDX for sensitivity, specificity, or overall diagnostic accuracy. Overall, the diagnostic accuracy of NMUS is similar to that of EDX for CTS diagnosis, with high sensitivity and moderate specificity for each. The choice between these confirmatory diagnostic tests should incorporate shared decision-making between patients and providers that weighs diagnostic accuracy as well as factors such as patient preferences, test availability, cost, and tolerability.

Keywords: carpal tunnel syndrome, nerve, diagnosis, diagnostic accuracy, electrodiagnostic study, neuromuscular ultrasound, meta-analysis

Introduction

Despite being the most common peripheral nerve compression syndrome, there remains notable disagreement on the optimal diagnostic workup for carpal tunnel syndrome (CTS). A recent survey of American Society for Surgery of the Hand membership noted that the majority of hand surgeons are still ordering and/or requiring electrodiagnostic studies (EDX) prior to performing surgery for CTS. 1 A number of studies have demonstrated similar or even superior diagnostic accuracy for neuromuscular ultrasound (NMUS) for diagnosis of CTS with improved efficiency and decreased cost.2 -4 In addition, patients clearly prefer and even promote the use of NMUS over EDX. 5 Utilization of NMUS rather than EDX may also improve the efficiency of treatment. 6

Prior studies comparing NMUS and EDX have suffered from small numbers, lack of formal statistical analysis of diagnostic accuracy, variable reference standards, and incomplete data that report only sensitivity or specificity. The lack of a universally accepted reference standard has made calculation of diagnostic accuracy of these tests challenging. Several authors have utilized the CTS-6 diagnostic tool as the reference standard, and those studies found similar diagnostic accuracy between NMUS and EDX.4,7 Another important factor is that the cutoff values chosen for both NMUS and EDX are based on optimizing the trade-off between false-positives and false-negatives and can be adjusted to maximize sensitivity or specificity, but not both. The physician must often decide if the testing is being used for screening or for confirmation. The prevalence of CTS in the practices being used for research may also artificially inflate the diagnostic accuracy of both NMUS and EDX.

Prior systematic reviews8,9 and commentaries10,11 have examined the benefits and limitations of NMUS vs EDX. In addition, one meta-analysis 12 compared NMUS to EDX for diagnosing CTS. However, it utilized unpaired sensitivity and specificity data for each test rather than direct comparative accuracy statistics. Because sensitivity and specificity have an inverse relationship, analyzing them independently fails to account for their interdependence and can lead to erroneous conclusions about overall test performance. In addition, varied reference standards were used rather than a consistent single standard. No meta-analysis has directly compared the diagnostic accuracy of NMUS and EDX using comparative data from the same studies and a clinical reference standard. This review aims to directly compare NMUS and EDX for accuracy in the diagnosis of CTS using a meta-analysis of paired accuracy studies. The null hypothesis is that there is no difference in the diagnostic accuracy of NMUS and EDX for diagnosis of CTS.

Materials and Methods

We developed and registered (researchregistry.com; reviewregistry1756) a systematic review protocol that adhered to the Preferred Reporting Items for Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies (PRISMA-DTA) guidelines. 13

Search Strategy and Selection Criteria

We systematically searched Medline, EMBASE, and the Cochrane Library without language restrictions to identify eligible studies published between January 2013 and September 2023. The Medline search terms are provided in Supplemental Table 1. Additional manual searches were conducted across the Directory of Open Access Journals, Google Scholar, and the reference lists of included articles and relevant systematic reviews. We included cross-sectional and case-control studies comparing NMUS and EDX to a clinical reference standard for CTS diagnosis. The clinical reference standards were either a CTS diagnosis from history and clinical examination alone or a CTS diagnosis based on questionnaire cutoff values derived from the clinical examination findings. Studies were excluded if they lacked sufficient data to construct 2 × 2 contingency tables for both NMUS and EDX, exclusively enrolled clinically-confirmed CTS cases (precluding specificity calculations), used EDX results to define the reference standard, or focused on special populations (eg, diabetics).

Data Extraction and Quality Assessment

Two reviewers independently extracted data and evaluated study quality using the Quality Assessment of Diagnostic Accuracy Studies 2 tool, which assesses risk of bias across four key domains: patient selection, index tests, reference standard, and flow/timing of risk of bias. 14 Each domain was judged as having low, high, or unclear risk of bias for each study. The overall risk of bias for each study was then categorized based on the individual domain ratings. When studies reported diagnostic data for multiple test criteria, we selected the criterion with the highest Youden’s index to optimize the balance of sensitivity and specificity. 15 Any discrepancies between the reviewers were resolved through consensus.

Data Analysis

We used bivariate random-effects regression models to estimate pooled sensitivity and specificity, with corresponding 95% confidence intervals, presented in coupled forest plots. Sensitivity refers to the proportion of true-positive CTS cases correctly identified by a test, while specificity reflects the proportion of true-negative CTS cases correctly ruled out. These models generated hierarchical summary receiver-operating characteristic (HSROC) curves, plotting sensitivity (true-positive rate) against 1-specificity (false-positive rate) to visualize the overall diagnostic accuracy. Hierarchical summary receiver-operating characteristic curves closer to the upper left corner indicated greater discriminatory ability to correctly classify CTS cases from non-cases. Additional metrics calculated from the pooled sensitivity and specificity estimates included positive (LR+) and negative (LR−) likelihood ratios and the diagnostic odds ratio (DOR). Likelihood ratios indicate how much a positive or negative test result changes the odds of having CTS. The DOR provides an overall measure of diagnostic test performance calculated as the ratio of the odds of a positive test in CTS patients relative to the odds in non-CTS patients. 16 Statistical comparisons between NMUS and EDX HSROC curves were made using the z-test on differences in model coefficients. Between-study heterogeneity was assessed with the bivariate I2 statistic but was not explored due to an insufficient number of included studies. The meta-analysis was performed using Meta-Disk version 2.0, and the results were exported to Review Manager to generate the forest plots and HSROC curves. P-values < .05 were considered statistically significant.

Results

After screening 81 full-text articles, 9 paired accuracy studies4,7,17 -23 with 1751 hands (743 clinically diagnosed with CTS; 1008 without CTS) who underwent NMUS and EDX were included (Supplemental Figure 1). Study characteristics are summarized in Table 1. Among the 9 included studies, the mean age ranged from 35 to 56 years, and the proportion of females ranged from 46% to 100%. The proportion of positive reference standard CTS diagnoses ranged from 6.6% to 90.4% across studies. For NMUS, the criterion for a positive test utilized the median nerve cross-sectional area (CSA) in 8 of 9 studies, which ranged from 8.8 to 13.0 mm2. For EDX, the diagnostic criteria were highly variable among studies, most commonly involving sensory conduction slowing and distal motor latency prolongation. Overall, the included studies exhibited low risks for concerns related to bias and applicability, except for the patient selection category where 5 of 9 studies used a case-control design (Supplemental Figure 2). Such study designs with disproportionate sampling of distinct CTS cases and non-cases can introduce selection bias, potentially inflating estimates of diagnostic test accuracy beyond values expected under routine clinical settings.

Table 1.

Characteristics of Included Studies.

Study Hands Age (y) Female sex Reference standard criterion Positive reference standard Positive neuromuscular ultrasound criterion Positive electrodiagnostic test criterion
Cartwright 17 513 35 46% Katz hand diagram score 2 or 3 6.6%
(34/513)
Median nerve CSA ≥ 13 mm2 Peak median-ulnar sensory latency difference > 0.6 ms
Chen 7 402 52 72% CTS-6 ≥ 12 64.9%
(261/402)
Median nerve CSA ≥ 10 mm2 Median nerve motor latency ≥4.0 ms, or median nerve sensory latency ≥3.5 ms, or CMAP ≤10 mV, or SNAP ≤6 μV, or median-ulnar nerve sensory latency ≥0.5 ms
Drakopoulos 18 192 — — Clinical diagnosis 50.0%
(96/192)
Median nerve CSA ≥12.2 mm2 Padua scale ≥1
El-Najjar 19 60 38 83% Clinical diagnosis 66.7%
(40/60)
Median nerve CSA >9.2 mm2 Padua scale ≥1
El-Shintenawy 20 86 37 96% Clinical diagnosis 65.1%
(56/86)
Flattening ratio at hamate >4 Sensory conduction velocity <50 m/s
Fowler 4 85 56 64% CTS-6 ≥12 64.7%
(55/85)
Median nerve CSA ≥10 mm2 Distal motor latency ≥4.2 ms or distal sensory latency ≥3.2 ms
Kanikannan 21 192 49 a 67% a Clinical diagnosis 47.9%
(92/192)
Median nerve CSA >11 mm2 Palm-wrist distal sensory latency difference >0.4 ms
Pimentel 22 115 53 100% CTS-6 ≥12 90.4%
(104/115)
Median nerve CSA ≥10 mm2 Sensory conduction velocity <50 m/s & distal motor latency ≥4.2 ms
Singla 23 106 43 71% Clinical diagnosis 52.8%
(56/106)
Median nerve CSA ≥8.8 mm2 Distal sensory latency >3.6 ms

Note. CMAP = compound muscle action potential; CSA = cross-sectional area; CTS = carpal tunnel syndrome; SNAP = sensory nerve action potential.

a

Data reported in CTS cases only, although controls were age- and sex-matched.

The sensitivity and specificity of each test among individual studies are displayed in Figure 1. The pooled sensitivity was 86.4% (95% CI, 76.3%-92.7%) for NMUS and 91.6% (95% CI, 84.3%-95.6%) for EDX. Pooled specificity was 79.3% (95% CI, 64.3%-89.0%) for NMUS and 81.9% (95% CI, 68.1%-90.6%) for EDX. The corresponding LR+ was 4.2 (95% CI, 2.2-7.8) and 5.1 (95% CI, 2.7-9.5) for NMUS and EDX, respectively, and the LR− was 0.17 (95% CI, 0.09-0.32) and 0.10 (95% CI, 0.05-0.20). The DOR was 24 (95% CI, 8-74) for NMUS and 49 (95% CI, 16-150) for EDX. Moderate to high heterogeneity in diagnostic accuracy was observed, with a bivariate I2 of 79.5% for NMUS and 77.5% for EDX. Comparing NMUS and EDX, there were no statistically significant differences in sensitivity (P = .29), specificity (P = .76), or overall diagnostic accuracy (P = .57; Figure 2). The post-diagnostic test probability of CTS after NMUS or EDX based on a range of pre-diagnostic test probabilities is shown in Figure 3.

Figure 1.

Figure 1.

Forest plot of sensitivity and specificity of NMUS and EDX for diagnosis of carpal tunnel syndrome.

Note. EDX = electrodiagnostic studies; FN = false negative; FP = false positive; NMUS = neuromuscular ultrasound; TN = true negative; TP = true positive.

Figure 2.

Figure 2.

Summary receiver-operating characteristic curves of neuromuscular ultrasound (NMUS) and electrodiagnostic studies (EDX) for diagnosis of carpal tunnel syndrome.

Note. The open black ovals and red diamonds represent NMUS and EDX results from individual studies. The filled black and red markers indicate the pooled sensitivity and specificity for NMUS and EDX, respectively. The ellipses represent the 95% confidence region, the colored lines represent the summary receiver-operating characteristic curves, a black line connects the pair of points representing the two tests from each study, and the horizontal dashed line represents the line of no discrimination. The overall diagnostic accuracy of NMUS and EDX was comparable (P = .57).

Figure 3.

Figure 3.

Post-diagnostic test likelihood of carpal tunnel syndrome (CTS) with neuromuscular ultrasound (NMUS) and electrodiagnostic studies (EDX) based on prediagnostic test probabilities.

Note. The graph depicts postdiagnostic test probabilities of CTS based on varying prediagnostic test probabilities with results comparing NMUS to EDX. Solid lines with filled circular and diamond markers represent positive results for NMUS and EDX, respectively, while dashed lines and open markers denote negative test results. Each point on a line corresponds to the postdiagnostic test probability for a specific prediagnostic test probability.

Discussion

Synthesis of Evidence

This contemporary systematic review and meta-analysis demonstrated that NMUS and EDX have comparable diagnostic accuracy for CTS. These findings support using either NMUS or EDX for objective confirmatory evidence to support a clinically suspected CTS diagnosis. Regardless of the probability of CTS based on clinical examination, a positive NMUS or EDX result substantially increases the postdiagnostic test CTS probability. When the probability of CTS based on clinical examination is low to moderate, a negative NMUS or EDX result considerably reduces the postdiagnostic test probability of CTS, providing additional diagnostic confirmation. Thus, both tests are valuable for ruling in the diagnosis when the CTS probability derived from a clinical examination is high and for ruling out the diagnosis when the CTS probability is low to moderate. However, in situations with a high prediagnostic test probability such as patients with symptoms of CTS, a negative NMUS or EDX test does not entirely rule out CTS. Thus, it is essential to interpret the results of these tests within a broader clinical context. Importantly, while the pooled results demonstrate a comparable diagnostic accuracy between NMUS and EDX, the moderate to high heterogeneity observed among the included studies may limit the generalizability of these findings to specific clinical settings and patient populations. Ultimately, the choice between NMUS and EDX should incorporate shared decision-making between providers and patients that weighs their comparable diagnostic accuracy as well as practical factors such as patient preferences, availability, costs, and tolerability.

Comparison to Previous Studies

This meta-analysis provides high-quality evidence on the comparative diagnostic accuracy of NMUS and EDX for CTS, which was enabled by utilizing rigorous inclusion criteria and statistical methodology. Unlike previous reviews, we only included paired accuracy studies that assessed both tests in the same patient cohort and used clinical diagnosis as the sole reference standard. Furthermore, no previous reviews have utilized standard meta-analysis methods for diagnostic test accuracy studies. Consequently, by overcoming past review limitations, our findings provide strong evidence that NMUS and EDX have comparable overall accuracy for diagnosing CTS. Still, complementary insights can be drawn from other studies using different yet robust methodologies. Fowler et al, 3 using latent class analysis to compare NMUS to EDX, reported 91% sensitivity for both tests and 94% and 83% specificity, respectively. Latent class analysis estimates diagnostic test accuracy by identifying subgroups with and without disease based on patterns in the results rather than comparing them to an imperfect reference standard. In addition, an international Delphi panel concluded that the diagnostic accuracy of NMUS and EDX for CTS was comparable. 24 Lastly, a systematic review without meta-analysis by the American Association of Neuromuscular and Electrodiagnostic Medicine provided Level A evidence supporting NMUS accuracy for CTS diagnosis. 25 Thus, existing data from other methodologies confirm the comparability of NMUS and EDX identified in the current review.

Clinical Implications of Results

The American Academy of Orthopedic Surgeons clinical practice guideline for CTS diagnosis does not support NMUS, citing insufficient evidence based on a systematic review that concluded in February 2015. 26 Arguably, our contemporary review represents the highest quality evidence available for comparing the accuracy of NMUS and EDX. The findings suggest that NMUS may provide comparable diagnostic utility to EDX for CTS. This, combined with greater accessibility, a favorable cost-benefit profile, excellent patient tolerability, and 88% of patients preferring it over EDX, 27 provides a compelling rationale to update guidelines and recommend NMUS or EDX for confirmatory testing in patients with suspected CTS.

Barriers to adopting NMUS for CTS diagnosis exist but can be reasonably overcome. Provider unfamiliarity with NMUS can be addressed through expanded training in primary care, neurology, orthopedics, and rheumatology residencies, and hand surgery fellowships focused on educational initiatives to equip clinicians to perform and interpret NMUS studies. In a recent survey, over two-thirds of upper-extremity surgeons routinely used NMUS diagnostically, with nearly 6 in 10 having personal access to ultrasound equipment, representing substantial growth in recent years. 28 While NMUS accuracy partially depends on the ultrasonographer’s experience, 29 comprehensive training and standardized protocols can improve consistency, 30 which are also required for EDX. 31 With concerted efforts to implement provider training, optimize technological capabilities, and reduce variability, the routine adoption of NMUS as an alternative option alongside EDX for CTS diagnosis could be facilitated.

Economic Implications of Results

The findings demonstrating comparable diagnostic accuracy for NMUS and EDX have important economic implications given the significantly lower costs of NMUS. The direct costs of NMUS are considerably lower than those for EDX, with existing literature citing a $400 lower cost per study. 32 Additional indirect cost-savings arise since NMUS can be performed during the initial clinical visit when clinical symptoms are consistent with CTS, avoiding referrals to specialized electrodiagnostic laboratories and subspecialists that incur further costs. NMUS provides opportunity cost-savings by enabling point-of-care diagnosis and eliminating the need for an additional visit solely for confirmatory testing that represents lost productivity and patient time. The study of Charles and colleagues 6 demonstrated that patients receiving a CTS diagnosis by NMUS underwent carpal tunnel release 3 to 4 weeks earlier and had 1.8 fewer medical visits on average than those diagnosed with EDX. Thus, NMUS represents an attractive option to reduce unnecessary expenditures related to CTS diagnosis compared to the traditional standard of EDX, which is an important consideration given the rising pressures to deliver high-value care. However, as our study did not directly assess costs, further research is needed to quantify the economic impact of using NMUS as an alternative to EDX for CTS diagnosis.

Study Limitations

Several limitations existed in this meta-analysis. A key consideration is the use of a clinical diagnosis as the reference standard. Clinical criteria for diagnosing CTS varied among studies, which introduced the potential for disease misclassification. However, the clinical criteria used in this review were more consistent than those in previous reviews, which utilized EDX alone, the combination of EDX and clinical diagnosis, or mixed both criteria inconsistently as the reference standard. There was also variability in the diagnostic thresholds and definitions used for NMUS and especially EDX within studies. For NMUS, most studies relied on median nerve CSA cutoff values ranging from 8.8 to 13.0 mm2. For EDX, different studies utilized varying compound muscle action potential amplitudes, conduction velocities, and distal motor latencies to diagnose CTS. This diagnostic threshold and criteria variability may have influenced test sensitivity and specificity. Unfortunately, there were an insufficient number of studies to perform subgroup analysis or metaregression to identify variables that may have explained this variability. Next, this review could not determine whether NMUS could accurately discriminate by CTS severity since we used clinical diagnosis as the reference standard. However, several studies comparing NMUS to EDX have confirmed that NMUS results can be used to determine CTS severity.33,34 It is important to acknowledge that assessing the impact of diagnostic tests on treatment outcomes would provide a more comprehensive evaluation of their clinical utility, and this should be a focus of future studies. Next, the diagnostic accuracy of NMUS and EDX may be compromised in special populations such as diabetics,35,36 which necessitates cautious test interpretation. Finally, patient populations differed, with some studies recruiting severe presurgical cases, and others enrolling milder cases. Thus, the pooled findings may not be generalizable to populations that differ substantially from those enrolled in the included studies.

In conclusion, the diagnostic accuracy of NMUS is similar to that of EDX for CTS diagnosis, with high sensitivity and moderate specificity for each when using a clinical diagnosis reference standard. The choice between these confirmatory diagnostic tests should incorporate shared decision-making between patients and providers that weighs diagnostic accuracy as well as factors such as patient preferences, test availability, cost, and tolerability.

Supplemental Material

sj-docx-1-han-10.1177_15589447241278972 – Supplemental material for Diagnostic Accuracy of Neuromuscular Ultrasound vs. Electrodiagnostic Studies for Carpal Tunnel Syndrome: Systematic Review and Meta-analysis of Paired Accuracy Studies

Supplemental material, sj-docx-1-han-10.1177_15589447241278972 for Diagnostic Accuracy of Neuromuscular Ultrasound vs. Electrodiagnostic Studies for Carpal Tunnel Syndrome: Systematic Review and Meta-analysis of Paired Accuracy Studies by Larry E. Miller, Warren C. Hammert, Mark S. Rekant and John R. Fowler in HAND

sj-docx-2-han-10.1177_15589447241278972 – Supplemental material for Diagnostic Accuracy of Neuromuscular Ultrasound vs. Electrodiagnostic Studies for Carpal Tunnel Syndrome: Systematic Review and Meta-analysis of Paired Accuracy Studies

Supplemental material, sj-docx-2-han-10.1177_15589447241278972 for Diagnostic Accuracy of Neuromuscular Ultrasound vs. Electrodiagnostic Studies for Carpal Tunnel Syndrome: Systematic Review and Meta-analysis of Paired Accuracy Studies by Larry E. Miller, Warren C. Hammert, Mark S. Rekant and John R. Fowler in HAND

sj-tif-1-han-10.1177_15589447241278972 – Supplemental material for Diagnostic Accuracy of Neuromuscular Ultrasound vs. Electrodiagnostic Studies for Carpal Tunnel Syndrome: Systematic Review and Meta-analysis of Paired Accuracy Studies

Supplemental material, sj-tif-1-han-10.1177_15589447241278972 for Diagnostic Accuracy of Neuromuscular Ultrasound vs. Electrodiagnostic Studies for Carpal Tunnel Syndrome: Systematic Review and Meta-analysis of Paired Accuracy Studies by Larry E. Miller, Warren C. Hammert, Mark S. Rekant and John R. Fowler in HAND

sj-tif-2-han-10.1177_15589447241278972 – Supplemental material for Diagnostic Accuracy of Neuromuscular Ultrasound vs. Electrodiagnostic Studies for Carpal Tunnel Syndrome: Systematic Review and Meta-analysis of Paired Accuracy Studies

Supplemental material, sj-tif-2-han-10.1177_15589447241278972 for Diagnostic Accuracy of Neuromuscular Ultrasound vs. Electrodiagnostic Studies for Carpal Tunnel Syndrome: Systematic Review and Meta-analysis of Paired Accuracy Studies by Larry E. Miller, Warren C. Hammert, Mark S. Rekant and John R. Fowler in HAND

Acknowledgments

The authors thank Deborah Gains, MS, for assistance with the systematic review.

Footnotes

Ethical Approval: This was a meta-analysis of published literature; thus, institutional review board approval was not applicable.

Statement of Human and Animal Rights: This was a meta-analysis of published literature without direct human or animal involvement.

Statement of Informed Consent: This was a meta-analysis of published literature; thus, informed consent was not applicable.

The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: L.E.M. received fees from Sonex Health, Inc. while conducting the study. W.C.H. received fees from Sonex Health, Inc. for data safety monitoring board participation, unrelated to this study. M.S.R. received fees from Sonex Health, Inc. for data safety monitoring board participation, unrelated to this study. J.R.F. serves as a uncompensated advisor to Sonex Health, Inc.

Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by Sonex Health, Inc. The sponsor was not involved in the study design; collection, analysis, and interpretation of data; writing of the report; or in the decision to submit the article for publication.

Supplemental material is available in the online version of the article.

References

  • 1. Billig JI, Sears ED. Utilization of diagnostic testing for carpal tunnel syndrome: a survey of the American Society for Surgery of the Hand. J Hand Surg Am. 2022;47(1):11-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Fowler JR, Gaughan JP, Ilyas AM. The sensitivity and specificity of ultrasound for the diagnosis of carpal tunnel syndrome: a meta-analysis. Clin Orthop Relat Res. 2011;469(4):1089-1094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Fowler JR, Cipolli W, Hanson T. A comparison of three diagnostic tests for carpal tunnel syndrome using latent class analysis. J Bone Joint Surg Am. 2015;97(23):1958-1961. [DOI] [PubMed] [Google Scholar]
  • 4. Fowler JR, Munsch M, Tosti R, et al. Comparison of ultrasound and electrodiagnostic testing for diagnosis of carpal tunnel syndrome: study using a validated clinical tool as the reference standard. J Bone Joint Surg Am. 2014;96(17):e148. [DOI] [PubMed] [Google Scholar]
  • 5. Carrozzi S, Schulz W, Beckwitt CH, et al. Patients prefer ultrasound to nerve conduction studies for the diagnosis of carpal tunnel syndrome. Plast Reconstr Surg Glob Open. 2023;11(9):e5279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Charles S, Oommen K, Ong J, et al. Use of ultrasound in patients with carpal tunnel syndrome: a cost-effective solution to reduce delays in surgical care. J Hand Surg Am. 2022;47(10):1018.e1-1018.e6 [DOI] [PubMed] [Google Scholar]
  • 7. Chen J, Fowler JR. Comparison of diagnostic accuracy of electrodiagnostic testing and ultrasonography for carpal tunnel syndrome. Hand. 2023;18(3):407-412 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Roll SC, Case-Smith J, Evans KD. Diagnostic accuracy of ultrasonography vs. electromyography in carpal Tunnel syndrome: a systematic review of literature. Ultrasound Med Biol. 2011;37(10):1539-1553. [DOI] [PubMed] [Google Scholar]
  • 9. Bennett OM, Sears ED. The impact of reference standard on diagnostic testing characteristics for carpal tunnel syndrome: a systematic review. Plast Reconstr Surg Glob Open. 2023;11(7):e5067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Fowler JR. Nerve conduction studies for carpal tunnel syndrome: gold standard or unnecessary Evil? Orthopedics. 2017;40(3):141-142. [DOI] [PubMed] [Google Scholar]
  • 11. Sonoo M, Menkes DL, Bland JDP, et al. Nerve conduction studies and EMG in carpal tunnel syndrome: do they add value. Clin Neurophysiol Pract. 2018;3:78-88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Zaki HA, Shaban E, Salem W, et al. A comparative analysis between ultrasound and electromyographic and nerve conduction studies in diagnosing carpal tunnel syndrome (CTS): a systematic review and meta-analysis. Cureus. 2022;14(10):e30476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Salameh JP, Bossuyt PM, McGrath TA, et al. Preferred reporting items for systematic review and meta-analysis of diagnostic test accuracy studies (PRISMA-DTA): explanation, elaboration, and checklist. BMJ. 2020;370:m2632. [DOI] [PubMed] [Google Scholar]
  • 14. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529-536. [DOI] [PubMed] [Google Scholar]
  • 15. Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32-35. [DOI] [PubMed] [Google Scholar]
  • 16. Glas AS, Lijmer JG, Prins MH, et al. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003;56(11):1129-1135. [DOI] [PubMed] [Google Scholar]
  • 17. Cartwright MS, Walker FO, Blocker JN, et al. Ultrasound for carpal tunnel syndrome screening in manual laborers. Muscle Nerve. 2013;48(1):127-131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Drakopoulos D, Mitsiokapa E, Karamanis E, et al. Ultrasonography provides a diagnosis similar to that of nerve conduction studies for carpal tunnel syndrome. Orthopedics. 2019;42(5):e460-e464. [DOI] [PubMed] [Google Scholar]
  • 19. El-Najjar AR, Abu-Elsoaud AM, Sabbah DA, et al. Emerging role of ultrasonography in the diagnosis of carpal tunnel syndrome: relation to risk factors, clinical and electrodiagnostic severity. The Egyptian Rheumatologist. 2021;43(4):341-345. [Google Scholar]
  • 20. El-Shintenawy AA, Kassem EM, El-Saadany HM, et al. Diagnostic potential of high resolution ultrasound and nerve conduction study in patients with idiopathic carpal tunnel syndrome. The Egyptian Rheumatologist. 2019;41(1):71-75. [Google Scholar]
  • 21. Kanikannan MA, Boddu DB, Sarva S, et al. Comparison of high-resolution sonography and electrophysiology in the diagnosis of carpal tunnel syndrome. Ann Indian Acad Neurol. 2015;18(2):219-225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Pimentel BFR, Faloppa F, Tamaoki MJS, et al. Effectiveness of ultrasonography and nerve conduction studies in the diagnosing of carpal tunnel syndrome: clinical trial on accuracy. BMC Musculoskelet Disord. 2018;19(1):115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Singla M, Sharma MK, Khurana D, et al. Role of high frequency ultrasound in diagnosing carpal tunnel syndrome as compared with conventional nerve conduction studies. Ann Indian Acad Neurol. 2020;23(5):649-655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Pelosi L, Arányi Z, Beekman R, et al. Expert consensus on the combined investigation of carpal tunnel syndrome with electrodiagnostic tests and neuromuscular ultrasound. Clin Neurophysiol. 2022;135:107-116. [DOI] [PubMed] [Google Scholar]
  • 25. Cartwright MS, Hobson-Webb LD, Boon AJ, et al. Evidence-based guideline: neuromuscular ultrasound for the diagnosis of carpal tunnel syndrome. Muscle Nerve. 2012;46(2):287-293. [DOI] [PubMed] [Google Scholar]
  • 26. American Academy of Orthopaedic Surgeons. Management of Carpal Tunnel Syndrome Evidence-Based Clinical Practice Guideline. American Academy of Orthopaedic Surgeons; 2016. [DOI] [PubMed] [Google Scholar]
  • 27. Badry AE, Sherif ME, Yoshimine T. Can sonography replace electromyography and nerve conduction velocity in carpal tunnel syndrome? International Neuropsychiatric Disease Journal. 2016;6(4):1-10. [Google Scholar]
  • 28. Demino C, Koesarie K, Smith J, et al. Ultrasound use by upper extremity surgeons in 2020: a survey of ASSH Members. Hand. 2023;18(7):1222-1229 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Crasto JA, Scott ME, Fowler JR. Ultrasound measurement of the cross-sectional area of the median nerve: the effect of teaching on measurement accuracy. Hand. 2019;14(2):155-162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Chen YT, Williams L, Zak MJ, et al. Review of ultrasonography in the diagnosis of carpal tunnel syndrome and a proposed scanning protocol. J Ultrasound Med. 2016;35(11):2311-2324. [DOI] [PubMed] [Google Scholar]
  • 31. Werner RA, Andary M. Electrodiagnostic evaluation of carpal tunnel syndrome. Muscle & Nerve. 2011;44(4):597-607. [DOI] [PubMed] [Google Scholar]
  • 32. Greenfield PT, Spencer CC, Dawes A, et al. The preoperative cost of carpal tunnel syndrome. J Hand Surg Am. 2022;47(8):752-761. [DOI] [PubMed] [Google Scholar]
  • 33. Hacker E, Goitz RJ, Fowler JR. Does patient sex affect ultrasound cutoff values for severity grading of carpal tunnel syndrome. J Hand Surg Am. 2021;46(10):862-867. [DOI] [PubMed] [Google Scholar]
  • 34. Lin TY, Chang KV, Wu WT, et al. Ultrasonography for the diagnosis of carpal tunnel syndrome: an umbrella review. J Neurol. 2022;269(9):4663-4675. [DOI] [PubMed] [Google Scholar]
  • 35. Heiling B, Wiedfeld L, Muller N, et al. Electrodiagnostic testing and nerve ultrasound of the carpal tunnel in patients with type 2 diabetes. J Clin Med. 2022;11(12):3374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Tony AA, Tony EA, Selim YA, et al. Carpal tunnel syndrome in patients with and without diabetes mellitus in upper egypt: the impact of electrophysiological and ultrasonographical studies. Alexandria Journal of Medicine. 2018;54(4):437-443. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

sj-docx-1-han-10.1177_15589447241278972 – Supplemental material for Diagnostic Accuracy of Neuromuscular Ultrasound vs. Electrodiagnostic Studies for Carpal Tunnel Syndrome: Systematic Review and Meta-analysis of Paired Accuracy Studies

Supplemental material, sj-docx-1-han-10.1177_15589447241278972 for Diagnostic Accuracy of Neuromuscular Ultrasound vs. Electrodiagnostic Studies for Carpal Tunnel Syndrome: Systematic Review and Meta-analysis of Paired Accuracy Studies by Larry E. Miller, Warren C. Hammert, Mark S. Rekant and John R. Fowler in HAND

sj-docx-2-han-10.1177_15589447241278972 – Supplemental material for Diagnostic Accuracy of Neuromuscular Ultrasound vs. Electrodiagnostic Studies for Carpal Tunnel Syndrome: Systematic Review and Meta-analysis of Paired Accuracy Studies

Supplemental material, sj-docx-2-han-10.1177_15589447241278972 for Diagnostic Accuracy of Neuromuscular Ultrasound vs. Electrodiagnostic Studies for Carpal Tunnel Syndrome: Systematic Review and Meta-analysis of Paired Accuracy Studies by Larry E. Miller, Warren C. Hammert, Mark S. Rekant and John R. Fowler in HAND

sj-tif-1-han-10.1177_15589447241278972 – Supplemental material for Diagnostic Accuracy of Neuromuscular Ultrasound vs. Electrodiagnostic Studies for Carpal Tunnel Syndrome: Systematic Review and Meta-analysis of Paired Accuracy Studies

Supplemental material, sj-tif-1-han-10.1177_15589447241278972 for Diagnostic Accuracy of Neuromuscular Ultrasound vs. Electrodiagnostic Studies for Carpal Tunnel Syndrome: Systematic Review and Meta-analysis of Paired Accuracy Studies by Larry E. Miller, Warren C. Hammert, Mark S. Rekant and John R. Fowler in HAND

sj-tif-2-han-10.1177_15589447241278972 – Supplemental material for Diagnostic Accuracy of Neuromuscular Ultrasound vs. Electrodiagnostic Studies for Carpal Tunnel Syndrome: Systematic Review and Meta-analysis of Paired Accuracy Studies

Supplemental material, sj-tif-2-han-10.1177_15589447241278972 for Diagnostic Accuracy of Neuromuscular Ultrasound vs. Electrodiagnostic Studies for Carpal Tunnel Syndrome: Systematic Review and Meta-analysis of Paired Accuracy Studies by Larry E. Miller, Warren C. Hammert, Mark S. Rekant and John R. Fowler in HAND


Articles from Hand (New York, N.Y.) are provided here courtesy of American Association for Hand Surgery

RESOURCES